Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.

Try Elite for Free

Q

QNCX

Quince Therapeutics Inc

31.00

Sep 21 • 3:59 PM ET +1.52 (5.16%)

30.72

Aftermarket • 7:52 PM ET -0.28 (-0.90%)

Healthcare Biotechnology USA Nano NASD

Peers: AEON BCTX CLRB CTXR LGVN LPCN PASG TPST CRIS TRAW

Scroll to Statements

Index	-
Market Cap	31.53M
Enterprise Value	59.36M
Income	-92.48M
Sales	0.00M
Book/sh	-34.73
Cash/sh	114.05
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	38
IPO	May 09, 2019

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	-
P/C	0.27
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	14.52
Current Ratio	14.52
Debt/Eq	0.00
LT Debt/Eq	0.00
Option/Short	No / Yes

EPS (ttm)	-125.60
EPS next Y	-8.09
EPS next Q	-1.13
EPS this Y	-
EPS next Y	-
EPS next 5Y	74.28%
EPS past 3/5Y	-2.82% 8.64%
Sales past 3/5Y	- -
EPS Y/Y TTM	43.02%
Sales Y/Y TTM	-
EPS Q/Q	82.10%
Sales Q/Q	-
Earnings	Aug 14 BMO
EPS/Sales Surpr.	56.07% -

Insider Own	3.52%
Insider Trans	0.00%
Inst Own	33.89%
Inst Trans	-4.78%
ROA	-76.68%
ROE	-153.84%
ROIC	-85.24%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	1.46%
SMA50	13.02%
SMA200	-79.35%
Trades

Shs Outstand	1.02M
Shs Float	0.98M
Short Float	5.82%
Short Ratio	1.86
Short Interest	0.06M
52W High	909.98 -96.59%
52W Low	15.10 105.30%
Volatility	8.90% 7.52%
ATR (14)	2.38
RSI (14)	55.09
Beta	1.34
Rel Volume	0.45
Avg Volume	30.64K
Volume	13,675

Perf Week	8.43%
Perf Month	-3.46%
Perf Quarter	67.10%
Perf Half Y	93.75%
Perf YTD	-95.37%
Perf Year	-90.31%
Perf 3Y	-86.75%
Perf 5Y	-99.82%
Perf 10Y	-
Recom	1.00
Target Price	75.17
Prev Close	29.48
Price	31.00
Change %	5.16%

Affiliate • Advertise • API and Exports • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)